Zhou Man-Ci, Fei Yu-Tong, Lai Xiao-Zhen, Lan Jian, Liu Bo, Wang Zhi-Wei, Fang Hai, Liu Jian-Ping, Rong Hong-Guo
Institute for Excellence in Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
School of Management, Beijing University of Chinese Medicine, Beijing, China.
Front Pharmacol. 2024 Sep 6;15:1425940. doi: 10.3389/fphar.2024.1425940. eCollection 2024.
The World Health Organization advocated for enhanced integration of traditional medicine and complementary medicine into national healthcare systems across all countries. This study aims to explore the progress and challenges in integrated traditional Chinese and western medicine (ITCWM) in China over 20 years using nationwide data.
This cross-sectional study examined various facets of ITCWM in China in terms of policies, resources, services, and funding. National policy documents from 2009 onwards were retrieved from official websites of the Chinese government. Data on ITCWM resources, services and subsidies from 2002 to 2021 were extracted from the China Statistical Yearbooks of Chinese Medicine and China Health Statistical Yearbooks. Research fund projects with the ITCWM discipline were collected from the database of National Natural Science Foundation of China. A mixed method of both quantitative and qualitative approaches was employed to present a comprehensive overview of the collected data.
This study presented five key findings. First, despite the issuance of 17 national policies by the Chinese government since 2009 to promote the development of traditional Chinese medicine (TCM), only three of them were specifically tailored for ITCWM. Second, although the average annual growth rates of ITCWM institutions, beds, and practitioners reached 0.35%, 10.56%, and 10.88% from 2002 to 2021, with more equitable allocation of ITCWM resources, the overall proportion of ITCWM remained below 5% in 2021. Third, progress has been made in ITCWM practices, yet service efficiency requires further enhancement. In 2021, ITCWM hospitals accounted for 2% of outpatient and emergency visits and 1.57% of hospital admissions among all hospitals, and 9.82% of delivered services were preventive healthcare services. Fourth, ITCWM served a crucial role in primary healthcare services, but its service capabilities need improvement. From 2007 to 2021, the average growth rates of ITCWM clinics, outpatient departments, and practitioners in outpatient departments were 13.30%, 2.57%, and 12.14%, respectively, while the proportion within TCM hospitals dropped. Lastly, despite the Chinese government's emphasis on financial investment and related project funding for ITCWM, it remained lower than that allocated to TCM and western medicine.
ITCWM played a pivotal role in China's healthcare system to advance individuals' health and well-being across the lifespan. In the future, China will provide further support to enhance ITCWM health resources and improve service capability, and the strategic integration of ITCWM into the broader healthcare system will play a crucial role in achieving universal health coverage and the Sustainable Development Goals.
世界卫生组织倡导各国加强将传统医学和补充医学纳入国家医疗保健系统。本研究旨在利用全国性数据探讨20年来中国中西医结合的进展与挑战。
本横断面研究从政策、资源、服务和资金等方面考察了中国中西医结合的各个方面。从中国政府官方网站检索了2009年以来的国家政策文件。从《中国中医药统计年鉴》和《中国卫生统计年鉴》中提取了2002年至2021年中西医结合资源、服务和补贴的数据。从国家自然科学基金数据库中收集了中西医结合学科的研究基金项目。采用定量和定性相结合的混合方法对收集到的数据进行全面概述。
本研究提出了五项主要发现。第一,尽管自2009年以来中国政府发布了17项国家政策以促进中医药发展,但其中只有三项是专门针对中西医结合的。第二,尽管2002年至2021年中西医结合机构、床位和从业人员的年均增长率分别达到0.35%、10.56%和10.88%,中西医结合资源分配更加公平,但2021年中西医结合的总体占比仍低于5%。第三,中西医结合实践取得了进展,但服务效率仍需进一步提高。2021年,中西医结合医院在所有医院的门诊和急诊就诊量中占2%,住院量中占1.57%,提供的服务中有9.82%是预防保健服务。第四,中西医结合在基层医疗服务中发挥了关键作用,但其服务能力有待提高。2007年至2021年,中西医结合诊所、门诊部和门诊部从业人员的平均增长率分别为13.30%、2.57%和12.14%,而在中医医院中的占比下降。最后,尽管中国政府重视对中西医结合的财政投入和相关项目资金,但仍低于对中医和西医的投入。
中西医结合在中国医疗保健系统中发挥了关键作用,促进了人们一生的健康和福祉。未来,中国将进一步提供支持,以加强中西医结合的卫生资源,提高服务能力,将中西医结合战略融入更广泛的医疗保健系统将在实现全民健康覆盖和可持续发展目标方面发挥关键作用。